Bert Klebl
8Patents
3h-index
53Co-inventors
56Inventor score
Filing activity: Nov 26, 2003 → Jul 23, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8084457B2 | Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases | Chemistry; Metallurgy | 75 | Expired |
| US8999982B2 | Pharmaceutically active compounds as Axl inhibitors | Chemistry; Metallurgy | 5 | Active |
| US9242937B2 | Pharmaceutically active disubstituted pyridine derivatives | Human Necessities | 4 | Active |
| US8507498B2 | 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases | Chemistry; Metallurgy | 3 | Active |
| US11111238B2 | Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer | Human Necessities | 0 | Active |
| US10703735B2 | 4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US7319024B1 | C. elegans p21-activated kinase (PAK) gene and associated loss-of-function phenotypes that facilitate screening for small molecule modulators of PAK activity in the nematode, caenorhabditis elegans | Chemistry; Metallurgy | 0 | Expired |
| US7341717B2 | Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.